↓ Skip to main content

Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma

Overview of attention for article published in Cochrane database of systematic reviews, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
f1000
1 research highlight platform

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
Published in
Cochrane database of systematic reviews, February 2013
DOI 10.1002/14651858.cd006246.pub2
Pubmed ID
Authors

T S Shylasree, Andrew Bryant, Ram Athavale

Abstract

Ovarian carcinosarcoma, also known as malignant mixed Mullerian tumour, is a rare malignant gynaecological tumour constituting about 1% or less of all ovarian cancers. In over 80% of cases, there is extra-ovarian intra-abdominal spread at diagnosis. The primary treatment has traditionally been surgical cytoreduction followed by radiotherapy and chemotherapy or chemotherapy alone. Regimes have included cisplatin alone; a combination of doxorubicin, ifosfamide, dacarbazine, cyclophosphamide, taxol; and various other combinations. The effectiveness of these various regimens appears to be mixed. Therefore, there is a need to clarify if there is an optimum neoadjuvant or adjuvant therapy after surgical cytoreduction for this rare tumour. Also, it is important to address quality of life (QoL) issues related to treatment, particularly toxicity, as the overall prognosis appears to be poor.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 18%
Student > Bachelor 7 13%
Student > Ph. D. Student 7 13%
Student > Doctoral Student 5 9%
Researcher 5 9%
Other 13 24%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 28 51%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Nursing and Health Professions 5 9%
Unspecified 2 4%
Psychology 2 4%
Other 3 5%
Unknown 10 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2013.
All research outputs
#7,554,525
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,637
of 8,923 outputs
Outputs of similar age
#72,909
of 143,901 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 106 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.